Surrounding each rare disease is a network of patients, parents, caregivers and key medical professionals, all of whom seek to develop new treatments. In many cases these networks have managed to identify new drug candidates and, in some cases, move them forward into animal models or early phase development. However, these programs commonly lack key resources, contacts, and the drug development expertise necessary to progress beyond the early phases of discovery. This is where Cerium Pharmaceuticals excels. Our team leverages the basic discovery work performed by others and enters after project feasibility is established. From this point, we create collaborative networks tailored to each project, which provide a wide range of support to new drug candidates. The goal of Cerium is to move these new medicines through the clinical development and regulatory processes and into final approval and availability.